<?xml version="1.0"?>
<rss version="2.0">
	<channel>
		<title>News (category : Partnerships and Licensing).</title>
		<link>http://www.lifescience-online.com/</link>
		<description>News Feed Powered by Lifescience-online.com</description>
		<language>en-us</language>
		<pubDate>Wed, 07 Jan 2009 13:23:30 +0100</pubDate>
		<lastBuildDate>Wed, 07 Jan 2009 13:23:30 +0100</lastBuildDate>
		<category>News</category>		

		<image>
			<title>Lifescience-online</title>
			<url>http://rss.lifescience-online.com/images/logo.gif</url>
			<link>http://www.lifescience-online.com/</link>
			<width></width>
			<height></height>
			<description>Lifescience-online</description>
		</image>

		<item>
			<title>PPD Enters Into Strategic Collaboration with Merck</title>
			<link>http://www.lifescience-online.com/PPD_Enters_Into_Strategic_Collaboration_with_Merck,13612.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/2.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/merck_and_co,885.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>MERCK AND CO INC</u></font></a><br /><a href='http://www.lifescience-online.com/ppd,10139.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>PPD Inc</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 04 Jan 2009 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Galapagos delivers pre-clinical candidate drug in alliance with GlaxoSmithKline and receives EURO 7.6 million in milestone payments</title>
			<link>http://www.lifescience-online.com/Galapagos_delivers_pre_clinical_candidate_drug_in_,13614.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Musculoskeletal System</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/glaxosmithkline,347.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>GLAXOSMITHKLINE PLC</u></font></a><br /><a href='http://www.lifescience-online.com/galapos_nv,9440.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>GALAPAGOS NV</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 04 Jan 2009 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Pfizer executes commercial license agreements for novel human vaccines based on Cytos Biotechnology&#039;s Immunodrug(TM) technology</title>
			<link>http://www.lifescience-online.com/Pfizer_executes_commercial_license_agreements_for_,13616.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/3.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/pfizer,651.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>PFIZER INC</u></font></a><br /><a href='http://www.lifescience-online.com/cytos_biotechnology,5481.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>CYTOS BIOTECHNOLOGY AG</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 04 Jan 2009 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Orexigen Therapeutics, Inc. (OREX) Issued a Key Fourth U.S. Patent on Contrave(R)</title>
			<link>http://www.lifescience-online.com/Orexigen_Therapeutics__Inc___OREX__Issued_a_Key_Fo,13633.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/1.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/orexigen_therapeutics,9573.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>OREXIGEN THERAPEUTICS INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/NALTREXONE_SR_+_BUPROPION_SR,21615.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>NALTREXONE SR + BUPROPION SR</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 04 Jan 2009 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Actavis Acquires Drug, Kadian for Under $127.5M; Extends Specialty Drug Portfolio in U.S.</title>
			<link>http://www.lifescience-online.com/Actavis_Acquires_Drug__Kadian_for_Under__127_5M__E,13572.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/1.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/alpharma,297.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ALPHARMA INC</u></font></a><br /><a href='http://www.lifescience-online.com/king_pharmaceuticals,826.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>KING PHARMACEUTICALS INC</u></font></a><br /><a href='http://www.lifescience-online.com/actavis_group,9559.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Actavis Group</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/MORPHINE_SULFATE,10504.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>MORPHINE SULFATE</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 29 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Sosei Group Corporation Announces Buyback of the Commercialization Rights to AD 923 from Mundipharma AG</title>
			<link>http://www.lifescience-online.com/Sosei_Group_Corporation_Announces_Buyback_of_the_C,13556.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/sosei_co,5040.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>SOSEI CO LTD</u></font></a><br /><a href='http://www.lifescience-online.com/mundipharma,6178.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>MUNDIPHARMA BV</u></font></a><br /><a href='http://www.lifescience-online.com/sirus_pharmaceuticals,6713.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>SIRUS PHARMACEUTICALS LTD</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/AD-923,7884.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>AD-923</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Thu, 25 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>SemBioSys Receives US$2.5 Million in Option Agreement with MannKind for Plant-produced Insulin</title>
			<link>http://www.lifescience-online.com/SemBioSys_Receives_US_2_5_Million_in_Option_Agreem,13550.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Metabolic Disease</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/mannkind,6062.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>MANNKIND Corp</u></font></a><br /><a href='http://www.lifescience-online.com/sembiosys_genetics,7769.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>SEMBIOSYS GENETICS INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/INSULIN_INHALED_(RECOMBINANT_HUMAN_INSULIN),384.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>INSULIN INHALED (RECOMBINANT HUMAN INSULIN)</u></font></a><br /><a href='http://www.lifescience-online.com/RECOMBINANT_HUMAN_INSULIN,2638.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>RECOMBINANT HUMAN INSULIN</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 23 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>King Pharmaceuticals(R), Inc. Exercises Option to License Fourth Opioid Product From Acura Pharmaceuticals, Inc.</title>
			<link>http://www.lifescience-online.com/King_Pharmaceuticals___Inc__Exercises_Option_to_Li,13557.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/2.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/acura_pharmaceuticals,263.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ACURA PHARMACEUTICALS INC</u></font></a><br /><a href='http://www.lifescience-online.com/king_pharmaceuticals,826.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>KING PHARMACEUTICALS INC</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 23 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

	</channel>
</rss>